Option 13: Treatment during pregnancy
Managing RA during pregnancy can be challenging, as some medications used to treat the condition may pose risks to the developing fetus. It is essential to work closely with your healthcare team to create a tailored treatment plan that prioritizes both your health and the health of your unborn child.
During pregnancy, some DMARDs, such as sulfasalazine and hydroxychloroquine, may be continued as they are considered relatively safe. However, other medications, like methotrexate and leflunomide, should be discontinued before conception due to their potential teratogenic effects. Biologic medications, such as TNF inhibitors, may be continued during pregnancy, but their use should be carefully discussed with your healthcare provider.
Low-dose corticosteroids, such as prednisone, are generally considered safe during pregnancy and can be used to manage RA symptoms if necessary. However, your healthcare provider may recommend adjusting the dosage or switching to an alternative medication to minimize potential risks to the fetus.
Non-pharmacological approaches, such as exercise, physical therapy, and joint protection strategies, can also play a crucial role in managing RA during pregnancy. These interventions can help alleviate symptoms and maintain joint function without the need for medications that may pose risks during pregnancy.
It is essential to maintain open communication with your healthcare team throughout pregnancy and after childbirth. This will allow for appropriate adjustments to your treatment plan as needed to ensure the best possible outcomes for both you and your baby. (13)
